Affluent Medical

Affluent Medical is a French medical technology company founded in 2011, specializing in innovative, minimally invasive prostheses aimed at restoring critical physiological functions. The company focuses on treating cardiovascular and urological diseases, which are significant health challenges worldwide. Affluent Medical is committed to becoming a European leader in these areas, leveraging a deep understanding of human physiology and collaboration with surgeons to create next-generation implants. The company's product portfolio includes the Kalios™ Mitral Annuloplasty Device and the Epygon Mitral Valve for structural heart disease, both designed to mimic natural anatomy and improve valve function. In urology, the Artus Electronic Sphincter addresses urinary incontinence, particularly in women, offering an adjustable and minimally invasive solution. Affluent Medical's devices undergo rigorous testing to ensure safety and efficacy, with ongoing clinical studies aimed at market introduction. The company employs around 66 people and has reported steady sales, with revenues of approximately €1.2 million in 2023.

• Employees 66
• Founded 2011
• Annual Revenue $4290000
• Total Funding $45543995